Johnson & Johnson (JNJ)

Total Current Liabilities

$54.90B

Quarterly · Period ending: · USD

JNJ logo

JNJ Total Current Liabilities

Latest reported$54.90B
JNJ Quarterly Current Liabilities ($1.17B → $54.90B)
High-resolution chart · PNG

JNJ total current liabilities history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Johnson & Johnson Total Current Liabilities — Quarterly (USD)
Period endingTotal Current Liabilities (USD)
54,895,000,000
57,716,000,000
54,126,000,000
50,869,000,000
54,180,000,000
56,903,000,000
50,321,000,000
51,759,000,000
53,933,000,000
48,725,000,000
46,282,000,000
44,370,000,000
54,170,000,000
60,373,000,000
55,802,000,000
45,543,000,000
44,821,000,000
43,390,000,000
45,226,000,000
44,561,000,000
38,721,000,000
40,932,000,000
42,493,000,000
38,847,000,000
36,772,000,000
33,689,000,000
35,964,000,000
35,162,000,000
31,353,000,000
29,111,000,000
31,230,000,000
27,437,000,000
27,488,000,000
27,081,000,000
30,537,000,000
31,806,000,000
28,872,000,000
25,119,000,000
26,287,000,000
23,230,000,000
21,536,000,000
22,134,000,000
27,747,000,000
25,260,000,000
24,512,000,000
23,836,000,000
25,031,000,000
22,982,000,000
24,359,000,000
23,840,000,000
25,675,000,000
25,835,000,000
23,767,000,000
22,524,000,000
24,262,000,000
23,935,000,000
23,848,000,000
21,198,000,000
22,811,000,000
21,686,000,000
20,985,000,000
24,011,000,000
23,072,000,000
17,414,000,000
17,164,000,000
18,499,000,000
21,731,000,000
19,245,000,000
19,886,000,000
21,325,000,000
20,852,000,000
22,730,000,000
21,780,000,000
22,071,000,000
19,837,000,000
19,328,000,000
18,983,000,000
19,663,000,000
19,161,000,000
12,063,000,000
12,189,000,000
13,192,000,000
12,635,000,000
12,047,000,000
11,640,000,000
12,981,000,000
13,927,000,000
12,329,000,000
12,062,000,000
12,449,000,000
13,448,000,000
12,782,000,000
12,836,000,000
11,457,000,000
11,449,000,000
10,701,000,000
10,567,000,000
8,301,000,000
8,044,000,000
7,504,000,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.